Legacy Wealth Management (Idaho)’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-50
Closed -$24.6K 890
2026
Q1
$24.6K Buy
50
+22
+79% +$11.9K 0.01% 352
2025
Q4
$16.2K Buy
28
+24
+600% +$13.6K 0.01% 353
2025
Q3
$1.94K Hold
4
﹤0.01% 546
2025
Q2
$1.62K Sell
4
-1
-20% -$418 ﹤0.01% 545
2025
Q1
$2.49K Hold
5
﹤0.01% 511
2024
Q4
$2.86K Sell
5
-37
-88% -$20.3K ﹤0.01% 457
2024
Q3
$22.8K Buy
+42
New +$24.9K 0.01% 205

Other funds holding TMO

Legacy Wealth Management (Idaho)'s TMO Position: Q2 2026 in Review

Legacy Wealth Management (Idaho) sold out of Thermo Fisher Scientific (TMO) in Q2 2026, closing a stake of 50 shares — an estimated $24.6K sold.

Legacy Wealth Management (Idaho) first reported a position in TMO in Q3 2024 and held it in 7 quarters. The position peaked at $24.6K in Q1 2026. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Legacy Wealth Management (Idaho) reported no remaining Thermo Fisher Scientific position as of Q2 2026 after selling out during the quarter.
  • Legacy Wealth Management (Idaho) sold 50 Thermo Fisher Scientific shares in Q2 2026, an estimated $24.6K.
  • Legacy Wealth Management (Idaho) first reported a position in Thermo Fisher Scientific in Q3 2024 and held it in 7 quarters.
  • Legacy Wealth Management (Idaho)'s Thermo Fisher Scientific position peaked at $24.6K in Q1 2026.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Legacy Wealth Management (Idaho)'s 13F filing for Q2 2026, filed 13 Aug 2026.